Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
Platform Therapeutics has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
Platform Therapeutics is headquartered in Andover, United States.
Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
Platform Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Platform Therapeutics — Funding & Investors." VCBacked, August 27, 2026, https://www.vcbacked.co/company/platform-therapeutics. Accessed September 3, 2026.
VCBacked. (2026). Platform Therapeutics — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/platform-therapeutics
{{cite web |title=Platform Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/platform-therapeutics |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated